Roels Elodie, Fastrès Aline, Merveille Anne-Christine, Bolen Géraldine, Teske Erik, Clercx Cécile, Mc Entee Kathleen
Department of Internal Medicine, Pride Veterinary Centre, DE24 8HX, Derby, United Kingdom.
Department of Clinical Sciences, Faculty of Veterinary Medicine, FARAH, University of Liege, 4000, Liege, Belgium.
BMC Vet Res. 2021 Apr 23;17(1):171. doi: 10.1186/s12917-021-02879-w.
Pulmonary hypertension (PH) is a known co-morbidity in West Highland white terriers (WHWTs) affected with canine idiopathic pulmonary fibrosis (CIPF). The pulmonary vein-to-right pulmonary artery ratio (PV/PA) has recently been described for the detection of pre-capillary PH in dogs. The objective of the present study was to estimate the prevalence of PH at diagnostic, in WHWTs affected with CIPF, by using PV/PA, in comparison with a group of healthy breed-matched controls (CTRLs). Additional study objective was to explore whether the presence of PH at initial diagnosis of CIPF impacted survival time in dogs treated with sildenafil.
Twenty-five client-owned WHWTs presented with CIPF and 19 CTRLs were included in the study. PV/PA in either two-dimensional mode (2D) or time-motion mode or both were measured from cineloops in each dog. Dogs were classified according to PV/PA value into non/mild PH (PV/PA measured in 2D ≥ 0.7) or moderate/severe PH (PV/PA < 0.7). Survival data of WHWTs affected with CIPF were extracted from medical record to assess association between presence of PH at diagnosis and outcome. 60 % overall prevalence for moderate/severe PH was estimated in this cohort of WHWTs presented with CIPF vs. 5 % in CTRLS (P = 0.0002). The presence of moderate/severe PH at initial presentation was not associated with survival.
Results of the present study confirm a high prevalence of PH at diagnosis in WHWTs affected with CIPF and highlight the utility of PV/PA as a non-invasive surrogate for assessment of PH in this population.
肺动脉高压(PH)是患有犬特发性肺纤维化(CIPF)的西部高地白梗(WHWTs)中已知的一种合并症。最近有人描述了肺静脉与右肺动脉比值(PV/PA)用于检测犬的毛细血管前性PH。本研究的目的是通过使用PV/PA,与一组健康的品种匹配对照(CTRLs)相比,估计患有CIPF的WHWTs在诊断时PH的患病率。另一项研究目的是探讨CIPF初诊时PH的存在是否会影响接受西地那非治疗的犬的生存时间。
25只客户拥有的患有CIPF的WHWTs和19只CTRLs被纳入研究。从每只犬的电影环中以二维模式(2D)或时间-运动模式或两者同时测量PV/PA。根据PV/PA值将犬分为非/轻度PH(二维测量的PV/PA≥0.7)或中度/重度PH(PV/PA<0.7)。从病历中提取患有CIPF的WHWTs的生存数据,以评估诊断时PH的存在与预后之间的关联。在这组患有CIPF的WHWTs中,中度/重度PH的总体患病率估计为60%,而在CTRLs中为5%(P = 0.0002)。初诊时存在中度/重度PH与生存无关。
本研究结果证实了患有CIPF的WHWTs在诊断时PH的高患病率,并强调了PV/PA作为评估该人群PH的非侵入性替代指标的实用性。